Haemonetics projects FY 2027 revenue growth of 4% to 7% as Persona PLUS rollout and IVT rebound efforts continue
Haemonetics Corporation · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $67.22
-5.2% in 1d after detection
Post-detection moves
1h
—
1d
-5.2%
3d
+3.4%
7d
+3.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS